5 employees
Mast Therapeutics is a biopharmaceutical company developing novel, clinical-stage therapies for serious or life-threatening diseases.
1995
$15M
from 2 investors over 2 rounds
Mast Therapeutics, Inc. raised $15M on March 1, 2016
Investors: Hercules Capital, Inc.
Mast Therapeutics, Inc. raised undisclosed on September 1, 2003
Investors: -